Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Parkinson's Disease”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Large-scale testing (Phase 3)Looking for participantsNCT07174310
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 900
Post-approval studies (Phase 4)Ended earlyNCT01048229
What this trial is testing

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
Qualissima 112
Testing effectiveness (Phase 2)Study completedNCT00407212
What this trial is testing

Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Who this might be right for
Parkinson's Disease
Novartis 301
Large-scale testing (Phase 3)Study completedNCT00594165
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Who this might be right for
Early-Stage Parkinson's Disease
UCB Pharma 217
Large-scale testing (Phase 3)Study completedNCT02864004
What this trial is testing

Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

Who this might be right for
Parkinson's Disease
Rennes University Hospital 134
Testing effectiveness (Phase 2)Study completedNCT02939391
What this trial is testing

KW-6356 in Subjects With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 175
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015841
What this trial is testing

Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease 6, Early-Onset
AC Immune SA 150
Testing effectiveness (Phase 2)Study completedNCT04995081
What this trial is testing

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 60
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Not applicableStudy completedNCT05308238
What this trial is testing

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

Who this might be right for
Parkinson Disease
San Jose State University 50
Not applicableUnknownNCT02100176
What this trial is testing

MIRT and Rotigotine in the Early Stage of PD

Who this might be right for
Parkinson's Disease
Ospedale Generale Di Zona Moriggia-Pelascini 40
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Not applicableStudy completedNCT03330470
What this trial is testing

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

Who this might be right for
Subjective Cognitive ImpairmentMild Cognitive ImpairmentParkinson Disease+1 more
Slovak Academy of Sciences 26
Early research (Phase 1)Looking for participantsNCT06608355
What this trial is testing

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Who this might be right for
Early-onset Parkinson's Disease
iRegene Therapeutics Co., Ltd. 6
Testing effectiveness (Phase 2)UnknownNCT03230526
What this trial is testing

Identification of a Biomarker Predictive of Evolution of Parkinson Disease

Who this might be right for
Parkinson Disease
Nantes University Hospital 31
Early research (Phase 1)Looking for participantsNCT07840027
What this trial is testing

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Idiopathic Parkinson's Disease
Tridem Bioscience FlexCo 36
Post-approval studies (Phase 4)Study completedNCT00402233
What this trial is testing

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 312
Not applicableActive Not RecruitingNCT04261569
What this trial is testing

Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)

Who this might be right for
Very Early Stage of Parkinson's Disease
University Hospital, Grenoble 14
Testing effectiveness (Phase 2)Study completedNCT00623324
What this trial is testing

The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

Who this might be right for
Early Stage Parkinson's Disease
Ligand Pharmaceuticals 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781644
What this trial is testing

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 474
Next Page